Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
A clinical trial evaluating the value of 68Ga-FAPI PET/CT imaging for assessing response to systemic therapy in patients with advanced unres…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer [Phase 1]
This clinical trial update reports that OH2, an oncolytic viral therapy, is being evaluated for advanced liver cancer via transarterial infu…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular Carcinoma [NA]
This clinical trial at the University of Aarhus is recruiting to compare MRI, CT, 18F-FDGal, and 18F-choline imaging in patients with hepato…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: 18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma [NA]
Ongoing clinical study evaluating 18F-FDGal PET/CT and PET/MRI imaging in hepatocellular carcinoma, currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC [Phase 2]
A Phase 2 clinical trial is evaluating a PD-L1 antibody in combination with bevacizumab and hepatic arterial infusion chemotherapy for advan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients. [Phase 2]
Phase 2 clinical trial evaluating HLX10 and HLX04 alone or with HLX53 for untreated locally advanced or metastatic hepatocellular carcinoma;…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating ZG005 plus Bevacizumab versus Sintilimab plus Bevacizumab in advanced hepatocellular carcinoma is currently recruit…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating the use of radiotherapy in combination with immunotherapy to downstage advanced hepatocellular c…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC [Phase 1, Phase 2]
Phase 1/2 study evaluating PM8002 in combination with PM1009 as first-line therapy for hepatocellular carcinoma. The trial status is not yet…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: LEOPARD Prospective Validation Cohort 1
This clinical trial update describes the LEOPARD prospective validation cohort 1 by Assistance Publique - Hôpitaux de Paris and lists condit…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors [Phase 2]
This clinical trials update describes a multicenter, open-label Phase IIa study to evaluate the efficacy and safety of B1962 injections in a…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 clinical trial evaluating perioperative pembrolizumab plus lenvatinib for resectable hepatocellular carcinoma is currently recruitin…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development
A recruiting clinical trial aims to characterize immune genotypes and antibody profiles to discover diagnostic biomarkers for liver cancer d…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China
An observational clinical trial evaluating SIR-Spheres therapy for hepatocellular carcinoma in China, currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: An Artificial Intelligence System for ROSE of EUS-FNA Sample: a Prospective, Multicenter, Diagnostic Study.
This clinical trial update describes a prospective multicenter study evaluating an AI-assisted ROSE system for EUS-FNA samples to diagnose m…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation [NA]
A clinical trial is evaluating an immunohistochemical algorithm for diagnosing and classifying hepatocellular carcinoma with mutations in TE…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Study on the Efficacy and Safety of Transarterial Chemoembolization Combined With Targeted Immunotherapy in Patients With Unresectable Hepatocellular Carcinoma
A clinical trial evaluating transarterial chemoembolization combined with targeted immunotherapy for unresectable hepatocellular carcinoma, …
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma [NA]
A clinical trial is currently recruiting to evaluate the combination of dTACE-HAIC with bevacizumab and atezolizumab for advanced hepatocell…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma [NA]
Ongoing clinical trial comparing TACE–lenvatinib with TACE–lenvatinib–ablation for intermediate recurrent hepatocellular carcinoma is curren…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC [NA]
A clinical trial evaluating donafenib as adjuvant therapy after microwave ablation for recurrent hepatocellular carcinoma is currently recru…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma
This clinical trial is evaluating ablation of pulmonary oligometastasis combined with systemic therapy in patients with advanced hepatocellu…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Spanish Registry of Digestive Tumours RETUD
This entry notes the RETUD Spanish registry for digestive tumours is currently recruiting, sponsored by the Spanish Cooperative Group for th…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation [Phase 2]
A Phase 2 clinical trial evaluating a downstaging protocol that includes immunotherapy for hepatocellular carcinoma patients beyond Milan cr…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC [NA]
A clinical trial is currently recruiting to evaluate the efficacy and safety of artificial liver support system (ALSS) for immune-mediated l…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
An observational registry study (SIRtain Registry) evaluating the use of SIR-Spheres Y-90 resin microspheres for unresectable liver tumors. …